Targeting postsynaptic glutamate receptor scaffolding proteins PSD-95 and PICK1 for obesity treatment
Science Advances · 2024
DOI: 10.1126/sciadv.adg2636 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Nicole Fadahunsi und 21 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Genome-Wide Association Study, Receptors, AMPA. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Human genome-wide association studies (GWAS) suggest a functional role for central glutamate receptor signaling and plasticity in body weight regulation. Here, we use UK Biobank GWAS summary statistics of body mass index (BMI) and body fat percentage (BF%) to identify genes encoding proteins known to interact with postsynaptic α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and N -methyl- d -aspartate (NMDA) receptors. Loci in/near discs large homolog 4 ( DLG4 ) and protein interacting with C kinase 1 ( PICK1 ) reached genome-wide significance ( P < 5 × 10 − 8 ) for BF% and/or BMI. To further evaluate the functional role of postsynaptic density protein-95 (PSD-95; gene name: DLG4 ) and PICK1 in energy homeostasis, we used dimeric PSD-95/disc large/ZO-1 (PDZ) domain–targeting peptides of PSD-95 and PICK1 to demonstrate that pharmacological inhibition of PSD-95 and PICK1 induces prolonged weight-lowering effects in obese mice. Collectively, these data demonstrate that the glutamate receptor scaffolding proteins, PICK1 and PSD-95, are genetically linked to obesity and that pharmacological targeting of their PDZ domains represents a promising therapeutic avenue for sustained weight loss.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark.
- Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
- Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Global Drug Discovery, Novo Nordisk A/S, Måløv, Denmark.
- Gubra, Hørsholm, Denmark.
ORCID-Profile: Nicole Fadahunsi, Sophia Metz, Alberte Silke Buch-Rasmussen, Nigel Kurgan, Jeppe Kjærgaard Larsen, Rita C Andersen, Charlotte Svendsen, Sara Elgaard Jager, Anders Bach, Atul S Deshmukh, Tuomas O Kilpeläinen, Kristian Strømgaard, Kenneth L Madsen, Christoffer Clemmensen
Zitieren
APA
Fadahunsi, N., Petersen, J., Metz, S., Jakobsen, A., Vad Mathiesen, C., Silke Buch-Rasmussen, A., Kurgan, N., Kjærgaard Larsen, J., Andersen, R. C., Topilko, T., Svendsen, C., Apuschkin, M., Skovbjerg, G., Hendrik Schmidt, J., Houser, G., Elgaard Jager, S., Bach, A., Deshmukh, A. S., Kilpeläinen, T. O., …, & Clemmensen, C. (2024). Targeting postsynaptic glutamate receptor scaffolding proteins PSD-95 and PICK1 for obesity treatment. Science Advances. https://doi.org/10.1126/sciadv.adg2636
Vancouver
Fadahunsi N, Petersen J, Metz S, Jakobsen A, Vad Mathiesen C, Silke Buch-Rasmussen A, et al. Targeting postsynaptic glutamate receptor scaffolding proteins PSD-95 and PICK1 for obesity treatment. Science Advances. 2024. doi:10.1126/sciadv.adg2636
BibTeX
@article{Fadahunsi2024,
author = {Fadahunsi, Nicole and Petersen, Jonas and Metz, Sophia and Jakobsen, Alexander and Vad Mathiesen, Cecilie and Silke Buch-Rasmussen, Alberte and Kurgan, Nigel and Kjærgaard Larsen, Jeppe and Andersen, Rita C and Topilko, Thomas and Svendsen, Charlotte and Apuschkin, Mia and Skovbjerg, Grethe and Hendrik Schmidt, Jan and Houser, Grace and Elgaard Jager, Sara and Bach, Anders and Deshmukh, Atul S and Kilpeläinen, Tuomas O and Strømgaard, Kristian and Madsen, Kenneth L and Clemmensen, Christoffer},
title = {Targeting postsynaptic glutamate receptor scaffolding proteins PSD-95 and PICK1 for obesity treatment},
journal = {Science Advances},
year = {2024},
doi = {10.1126/sciadv.adg2636}
}
EUVIMED